-
Je něco špatně v tomto záznamu ?
Detailed Characteristics of Tonsillar Tumors with Extrachromosomal or Integrated Form of Human Papillomavirus
B. Pokrývková, M. Saláková, J. Šmahelová, Z. Vojtěchová, V. Novosadová, R. Tachezy,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2009
Free Medical Journals
od 2009
PubMed Central
od 2009
Europe PubMed Central
od 2009
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2009
PubMed
31905862
DOI
10.3390/v12010042
Knihovny.cz E-zdroje
- MeSH
- DNA vazebné proteiny genetika MeSH
- genom virový * MeSH
- infekce papilomavirem virologie MeSH
- integrace viru * MeSH
- lidé MeSH
- lidský papilomavirus 16 genetika MeSH
- metylace DNA MeSH
- mutace MeSH
- onkogenní proteiny virové genetika MeSH
- tonzilární nádory virologie MeSH
- vazebná místa MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The human papillomavirus (HPV) integration, the critical step in viral carcinogenesis, most frequently occurs in the E2 gene, which results in its inactivation and in an increase of E6/E7 transcription. However, in a substantial number of tumors, the virus is present in an extrachromosomal form. For those tumors, the transformation mechanisms are not fully elucidated. Here we evaluated the possible mechanism of inactivating the E2 without interruption of the gene, methylation or mutation of the E2 binding sites (E2BSs) in HPV16-positive tonsillar tumors by next-generation and Sanger sequencing. Viral genome status was analyzed by the amplification of papillomavirus oncogene transcripts assay (APOT) and mRNA mapping, and expression of viral oncogenes was performed by qPCR. The methylation of E2BSs was significantly higher in tumors with an integrated, in comparison to extrachromosomal, form of the viral genome. No mutations were detected in the E2BSs. The viral oncogenes were equally expressed in samples with an integrated and extrachromosomal form of the virus. Only the nucleotide variants were identified in the E2 gene. No proposed mechanism of E2 inactivation was confirmed in tonsillar tumors with an extrachromosomal form of the HPV genome. The expression of E6/E7 genes seems to be sufficient to initiate and maintain the carcinogenic process.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025382
- 003
- CZ-PrNML
- 005
- 20201222160153.0
- 007
- ta
- 008
- 201125s2019 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/v12010042 $2 doi
- 035 __
- $a (PubMed)31905862
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Pokrývková, Barbora $u Department of Genetics and Microbiology, Faculty of Science, Charles University, BIOCEV, Průmyslová 595, 25250 Vestec, Czech Republic.
- 245 10
- $a Detailed Characteristics of Tonsillar Tumors with Extrachromosomal or Integrated Form of Human Papillomavirus / $c B. Pokrývková, M. Saláková, J. Šmahelová, Z. Vojtěchová, V. Novosadová, R. Tachezy,
- 520 9_
- $a The human papillomavirus (HPV) integration, the critical step in viral carcinogenesis, most frequently occurs in the E2 gene, which results in its inactivation and in an increase of E6/E7 transcription. However, in a substantial number of tumors, the virus is present in an extrachromosomal form. For those tumors, the transformation mechanisms are not fully elucidated. Here we evaluated the possible mechanism of inactivating the E2 without interruption of the gene, methylation or mutation of the E2 binding sites (E2BSs) in HPV16-positive tonsillar tumors by next-generation and Sanger sequencing. Viral genome status was analyzed by the amplification of papillomavirus oncogene transcripts assay (APOT) and mRNA mapping, and expression of viral oncogenes was performed by qPCR. The methylation of E2BSs was significantly higher in tumors with an integrated, in comparison to extrachromosomal, form of the viral genome. No mutations were detected in the E2BSs. The viral oncogenes were equally expressed in samples with an integrated and extrachromosomal form of the virus. Only the nucleotide variants were identified in the E2 gene. No proposed mechanism of E2 inactivation was confirmed in tonsillar tumors with an extrachromosomal form of the HPV genome. The expression of E6/E7 genes seems to be sufficient to initiate and maintain the carcinogenic process.
- 650 _2
- $a vazebná místa $7 D001665
- 650 _2
- $a metylace DNA $7 D019175
- 650 _2
- $a DNA vazebné proteiny $x genetika $7 D004268
- 650 12
- $a genom virový $7 D016679
- 650 _2
- $a lidský papilomavirus 16 $x genetika $7 D052162
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a onkogenní proteiny virové $x genetika $7 D009856
- 650 _2
- $a infekce papilomavirem $x virologie $7 D030361
- 650 _2
- $a tonzilární nádory $x virologie $7 D014067
- 650 12
- $a integrace viru $7 D016662
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Saláková, Martina $u Department of Genetics and Microbiology, Faculty of Science, Charles University, BIOCEV, Průmyslová 595, 25250 Vestec, Czech Republic.
- 700 1_
- $a Šmahelová, Jana $u Department of Genetics and Microbiology, Faculty of Science, Charles University, BIOCEV, Průmyslová 595, 25250 Vestec, Czech Republic.
- 700 1_
- $a Vojtěchová, Zuzana $u Department of Genetics and Microbiology, Faculty of Science, Charles University, BIOCEV, Průmyslová 595, 25250 Vestec, Czech Republic.
- 700 1_
- $a Novosadová, Vendula $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, BIOCEV, Průmyslová 595, 25250 Vestec, Czech Republic.
- 700 1_
- $a Tachezy, Ruth $u Department of Genetics and Microbiology, Faculty of Science, Charles University, BIOCEV, Průmyslová 595, 25250 Vestec, Czech Republic.
- 773 0_
- $w MED00177099 $t Viruses $x 1999-4915 $g Roč. 12, č. 1 (2019)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31905862 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222160149 $b ABA008
- 999 __
- $a ok $b bmc $g 1599527 $s 1116068
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 12 $c 1 $e 20191230 $i 1999-4915 $m Viruses $n Viruses $x MED00177099
- LZP __
- $a Pubmed-20201125